Request for Covid-19 Impact Assessment of this Report
The United States Gastrointestinal Therapeutics and Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gastrointestinal Therapeutics and Diagnostics market, reaching US$ million by the year 2028. As for the Europe Gastrointestinal Therapeutics and Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gastrointestinal Therapeutics and Diagnostics players cover Abbott Laboratories, AstraZeneca, Eisai, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Therapeutics and Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Diagnostics
Therapeutics
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Gastroenteritis
GI Bleeding
Irritable Bowel Syndrome
Peptic Ulcer Disease (PUD)
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
AstraZeneca
Eisai
Johnson & Johnson
Salix Pharmaceuticals
Takeda Pharmaceutical Company
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size 2017-2028
2.1.2 Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Gastrointestinal Therapeutics and Diagnostics Segment by Type
2.2.1 Diagnostics
2.2.2 Therapeutics
2.3 Gastrointestinal Therapeutics and Diagnostics Market Size by Type
2.3.1 Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2017-2022)
2.4 Gastrointestinal Therapeutics and Diagnostics Segment by Application
2.4.1 Gastroenteritis
2.4.2 GI Bleeding
2.4.3 Irritable Bowel Syndrome
2.4.4 Peptic Ulcer Disease (PUD)
2.4.5 Others
2.5 Gastrointestinal Therapeutics and Diagnostics Market Size by Application
2.5.1 Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2017-2022)
3 Gastrointestinal Therapeutics and Diagnostics Market Size by Player
3.1 Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Players
3.1.1 Global Gastrointestinal Therapeutics and Diagnostics Revenue by Players (2020-2022)
3.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global Gastrointestinal Therapeutics and Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gastrointestinal Therapeutics and Diagnostics by Regions
4.1 Gastrointestinal Therapeutics and Diagnostics Market Size by Regions (2017-2022)
4.2 Americas Gastrointestinal Therapeutics and Diagnostics Market Size Growth (2017-2022)
4.3 APAC Gastrointestinal Therapeutics and Diagnostics Market Size Growth (2017-2022)
4.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2017-2022)
5.2 Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022)
5.3 Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2017-2022)
6.2 APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022)
6.3 APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gastrointestinal Therapeutics and Diagnostics by Country (2017-2022)
7.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022)
7.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics by Region (2017-2022)
8.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.1 Global Gastrointestinal Therapeutics and Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global Gastrointestinal Therapeutics and Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas Gastrointestinal Therapeutics and Diagnostics Forecast
10.1.3 APAC Gastrointestinal Therapeutics and Diagnostics Forecast
10.1.4 Europe Gastrointestinal Therapeutics and Diagnostics Forecast
10.1.5 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Forecast
10.2 Americas Gastrointestinal Therapeutics and Diagnostics Forecast by Country (2023-2028)
10.2.1 United States Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.2.2 Canada Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.2.3 Mexico Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.2.4 Brazil Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3 APAC Gastrointestinal Therapeutics and Diagnostics Forecast by Region (2023-2028)
10.3.1 China Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.2 Japan Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.3 Korea Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.4 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.5 India Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.6 Australia Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4 Europe Gastrointestinal Therapeutics and Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4.2 France Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4.3 UK Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4.4 Italy Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4.5 Russia Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5.2 South Africa Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5.3 Israel Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5.4 Turkey Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5.5 GCC Countries Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.6 Global Gastrointestinal Therapeutics and Diagnostics Forecast by Type (2023-2028)
10.7 Global Gastrointestinal Therapeutics and Diagnostics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product Offered
11.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product Offered
11.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Eisai
11.3.1 Eisai Company Information
11.3.2 Eisai Gastrointestinal Therapeutics and Diagnostics Product Offered
11.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Eisai Main Business Overview
11.3.5 Eisai Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product Offered
11.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Salix Pharmaceuticals
11.5.1 Salix Pharmaceuticals Company Information
11.5.2 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product Offered
11.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Salix Pharmaceuticals Main Business Overview
11.5.5 Salix Pharmaceuticals Latest Developments
11.6 Takeda Pharmaceutical Company
11.6.1 Takeda Pharmaceutical Company Company Information
11.6.2 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product Offered
11.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Takeda Pharmaceutical Company Main Business Overview
11.6.5 Takeda Pharmaceutical Company Latest Developments
12 Research Findings and Conclusion
Table 1. Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Diagnostics
Table 3. Major Players of Therapeutics
Table 4. Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2017-2022)
Table 7. Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2017-2022)
Table 10. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Player (2020-2022)
Table 12. Gastrointestinal Therapeutics and Diagnostics Key Players Head office and Products Offered
Table 13. Gastrointestinal Therapeutics and Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Country (2017-2022)
Table 20. Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2017-2022)
Table 22. Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2017-2022)
Table 24. APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Region (2017-2022)
Table 26. APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2017-2022)
Table 28. APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2017-2022)
Table 30. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Country (2017-2022)
Table 32. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2017-2022)
Table 34. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Gastrointestinal Therapeutics and Diagnostics
Table 43. Key Market Challenges & Risks of Gastrointestinal Therapeutics and Diagnostics
Table 44. Key Industry Trends of Gastrointestinal Therapeutics and Diagnostics
Table 45. Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Abbott Laboratories Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 52. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 53. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Abbott Laboratories Main Business
Table 55. Abbott Laboratories Latest Developments
Table 56. AstraZeneca Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 57. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 58. AstraZeneca Main Business
Table 59. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. AstraZeneca Latest Developments
Table 61. Eisai Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 62. Eisai Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 63. Eisai Main Business
Table 64. Eisai Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Eisai Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 67. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Johnson & Johnson Latest Developments
Table 71. Salix Pharmaceuticals Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 72. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 73. Salix Pharmaceuticals Main Business
Table 74. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Salix Pharmaceuticals Latest Developments
Table 76. Takeda Pharmaceutical Company Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 77. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 78. Takeda Pharmaceutical Company Main Business
Table 79. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Takeda Pharmaceutical Company Latest Developments
List of Figures
Figure 1. Gastrointestinal Therapeutics and Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type in 2021
Figure 7. Gastrointestinal Therapeutics and Diagnostics in Gastroenteritis
Figure 8. Global Gastrointestinal Therapeutics and Diagnostics Market: Gastroenteritis (2017-2022) & ($ Millions)
Figure 9. Gastrointestinal Therapeutics and Diagnostics in GI Bleeding
Figure 10. Global Gastrointestinal Therapeutics and Diagnostics Market: GI Bleeding (2017-2022) & ($ Millions)
Figure 11. Gastrointestinal Therapeutics and Diagnostics in Irritable Bowel Syndrome
Figure 12. Global Gastrointestinal Therapeutics and Diagnostics Market: Irritable Bowel Syndrome (2017-2022) & ($ Millions)
Figure 13. Gastrointestinal Therapeutics and Diagnostics in Peptic Ulcer Disease (PUD)
Figure 14. Global Gastrointestinal Therapeutics and Diagnostics Market: Peptic Ulcer Disease (PUD) (2017-2022) & ($ Millions)
Figure 15. Gastrointestinal Therapeutics and Diagnostics in Others
Figure 16. Global Gastrointestinal Therapeutics and Diagnostics Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application in 2021
Figure 18. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Player in 2021
Figure 19. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Gastrointestinal Therapeutics and Diagnostics Market Size 2017-2022 ($ Millions)
Figure 21. APAC Gastrointestinal Therapeutics and Diagnostics Market Size 2017-2022 ($ Millions)
Figure 22. Europe Gastrointestinal Therapeutics and Diagnostics Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size 2017-2022 ($ Millions)
Figure 24. Americas Gastrointestinal Therapeutics and Diagnostics Value Market Share by Country in 2021
Figure 25. Americas Gastrointestinal Therapeutics and Diagnostics Consumption Market Share by Type in 2021
Figure 26. Americas Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application in 2021
Figure 27. United States Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Region in 2021
Figure 32. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application in 2021
Figure 33. China Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Country in 2021
Figure 40. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type in 2021
Figure 41. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application in 2021
Figure 42. Germany Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application in 2021
Figure 50. Egypt Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 56. APAC Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 57. Europe Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 59. United States Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 60. Canada Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 63. China Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 64. Japan Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 65. Korea Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 67. India Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 68. Australia Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 69. Germany Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 70. France Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 71. UK Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 72. Italy Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 73. Russia Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 74. Spain Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 77. Israel Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Gastrointestinal Therapeutics and Diagnostics Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...